Home / 2013 / May (page 6)

Monthly Archives: May 2013

Editor’s Note, DCMS #137

I just finished up a two day advisory board meeting for an insulin manufacturer. We looked at some new products and studies as well as new ideas about diabetes care. Part of our discussion had to do with the increased use of EMRs (electronic medical records), EHRs (electronic health records) and …

Read More »

Letter from the Editor, #677

This week I happened to run into a physician friend I had not seen for a while. While we were chatting, I noticed that he must have gotten at least six pages from his answering service. Each time he had to call in and listen to the operator describe the …

Read More »

Liptruzet® – A Lipid-lowering Combination

Liptruzet

  Liptruzet® – A Lipid-lowering Combination  The FDA has approved a new lipid-lowering combination tablet (Liptruzet) that includes atorvastatin and ezetimibe. The tablet is available as a once-daily tablet containing 10 mg of ezetimibe combined with 10, 20, 40, or 80 mg of atorvastatin, can be used to treat elevated …

Read More »

Brown Adipose Tissue Holds Weight Loss Potential

Researchers from Sweden have demonstrated that brown cells as well as "brite" cells exist in the neck region in adult humans. The "classical" brown fat tissue, common in newborns but previously not thought to be present in adults, has potent energy burning capacity. "If we can find out how to …

Read More »

Higher A1c Rates in Diabetes Patients Who Sleep Late

Type 2 diabetes patients who go to bed late and sleep in late showed higher BMI and A1c rates, had more depressive symptoms, and were more likely to require insulin. Patients who sleep late also tend to eat more calories at dinner, which may lead to negative metabolic effects, researchers …

Read More »